Universe Pharmaceuticals INC Interest Expense Nonoperating
Universe Pharmaceuticals INC (UPC) reported Interest Expense Nonoperating of $232.04 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-01-29
| Period end | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 12 month | Interest Expense Nonoperating 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | $232.04M 20-F · filed 2026-01-29 | ||
| 2024-09-30 | $278.17M 20-F · filed 2026-01-29 | $278.17K 20-F · filed 2025-04-29 | |
| 2024-03-31 | $136.61K 6-K · filed 2024-09-20 | ||
| 2023-09-30 | $156.79M 20-F · filed 2026-01-29 | $156.79K 20-F · filed 2025-04-29 | |
| 2023-03-31 | $74.57K 6-K · filed 2024-09-20 | ||
| 2022-09-30 | $162.40K 20-F · filed 2025-04-29 |